Evidence map›Paper›PMID 42374876›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Pd/C-Catalyzed Hydrogenation of CF

Thibaud Charvillat, Patrick Bernardelli, Marc Daumas, Xavier Pannecoucke, Vincent Ferey, Hassan Oulyadi, Muriel Sebban, Tatiana Besset

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thibaud CharvillatINSA Rouen Normandie, Univ Rouen Normandie, Univ Caen Normandie, ENSICAEN, CNRS, Institut CARMeN (UMR 6064), Rouen, France.
Patrick BernardelliSanofi R&D, 13 Quai Jules Guesde, Vitry Sur Seine, France.
Marc DaumasResponsable De C&BD Science & innovation, Sanofi-Aventis R&D, 371 Rue Du Prof. J. Blayac, Montpellier, France.
Xavier PannecouckeINSA Rouen Normandie, Univ Rouen Normandie, Univ Caen Normandie, ENSICAEN, CNRS, Institut CARMeN (UMR 6064), Rouen, France.
Vincent FereySanofi Winthrop Industrie/MSAT/ Site d'aramon, Route d'Avignon, Aramon, France.
Hassan OulyadiINSA Rouen Normandie, Univ Rouen Normandie, Univ Caen Normandie, ENSICAEN, CNRS, Institut CARMeN (UMR 6064), Rouen, France.
Muriel SebbanINSA Rouen Normandie, Univ Rouen Normandie, Univ Caen Normandie, ENSICAEN, CNRS, Institut CARMeN (UMR 6064), Rouen, France.
Tatiana BessetINSA Rouen Normandie, Univ Rouen Normandie, Univ Caen Normandie, ENSICAEN, CNRS, Institut CARMeN (UMR 6064), Rouen, France.ORCID https://orcid.org/0000-0003-4877-5270

Funding

European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme 758710French National Research Agency ANR-11-LABX-0029French National Research Agency ANR-18-EURE-0020Sanofi
6 · The paper itself

Abstract

A robust method for the hydrogenation of various pyridines substituted by CF

Indexed as

hydrogenationorganofluorine chemistryPd/C catalystpolysubstituted piperidinessynthetic developments

Identifiers

PMID42374876
PMCPMC13480836

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.